During a Feb. 15 hearing by the Select Subcommittee on the
Coronavirus Pandemic, Dr. Peter Marks FDA Director of the Center for Biologics
Evaluation and Research avoided answering a direct question posed by the subcommittee
regarding FDA's surveillance of the VAERS database for COVID-19 vaccine injuries.
Given that the mRNA vaccines are a new technology first rolled out to the
public during the COVID-19 pandemic, one would think that regulatory agencies would
carefully monitor safety, particularly since these vaccines were "mandated" by
the Biden Administration OSHA division and many corporations.
I know from personal experience how hazardous the mRNA technology can be, and
I am truly outraged that evidence deemed negative is being ignored and/or censored (as "mal" or "dis" information) while criticism of the vaccines is literally being criminalized.
IGNORING EVIDENCE OF HARM
Dr. Marks referred the question about hazard surveillance to Dr.
Daniel Jernigan, director of the National Center for Emerging and Zoonotic
Infectious Diseases. Jernigan’s response not only lacks empirical support, but
contradicts well documented research findings regarding mRNA vaccine risks:
Megan Redshaw 2/15/2024 Updated: 2/16/2024). US Officials
Concede No Active Surveillance on Long-Term Effects of COVID-19 Vaccines. Epoch
Times https://www.theepochtimes.com/health/us-officials-concede-no-active-surveillance-on-long-term-effects-of-covid-19-vaccines-5588199?utm_source=ref_share&utm_campaign=copy
“So with regard to myocarditis, we certainly have been
monitoring the issue with various different data systems. I think the most
recent data really demonstrates that you’re about eight times less likely to
get myocarditis if you’re vaccinated compared to those that are unvaccinated,”
Dr. Daniel Jernigan, director of the National Center for Emerging and Zoonotic
Infectious Diseases at the CDC responded.
Apparently, Dr. Jernigan hasn’t read the following important study
conducted in Israel that found myocarditis coincided with the vax
rollouts, not the virus effects:
Sun, C.L.F., Jaffe, E. & Levi, R. Increased emergency
cardiovascular events among under-40 population in Israel during vaccine
rollout and third COVID-19 wave. Sci Rep 12, 6978 (2022).
https://doi.org/10.1038/s41598-022-10928-z
Why would Dr. Jernigan state an uncertain finding of vaccine safety with such inappropriately exaggerated confidence and in so doing trivialize the well-documented risk of myocarditis in young men?
Note that he absolves responsibility for his assertion with the legal out of a
faulty recollection through his “I think” caveat.
Notwithstanding his dissembling, what could be motivating this push to
promote endless mRNA COVID-19 vaccine boosters and mRNA tech with no
consideration of safety risks? What is going on here? Is this where we find ourselves?
Crutchfield P. Compulsory moral
bioenhancement should be covert. Bioethics. 2019 Jan;33(1):112-121. doi:
10.1111/bioe.12496. Epub 2018 Aug 29. PMID: 30157295.
Or is the answer as simply as the reduction of human life into livestock for experimentation and exploitation?
DOCUMENTATION OF LACK OF TRANSPARENCY
"The C.D.C.
Isn’t Publishing Large Portions of the Covid Data It Collects" The New
York Times https://www.nytimes.com/2022/02/20/health/covid-cdc-data.html
SHUTTING DOWN INTERNAL DISSENT
Marty Makary April 3, 2022 FDA Shuts Out Its Own Experts in
Authorizing Another Vaccine Booster. The Wall Street Journal, https://www.wsj.com/articles/fda-shuts-out-its-own-experts-in-authorizing-another-booster-covid-vaccine-pandemic-science-11649016728
Decisions like this only reinforce the perception that
Covid policy is driven by groupthink and politics... Another committee member, Cody Meissner, agrees. Dr.
Meissner, chief of pediatric infectious diseases at Tufts Children’s Hospital,
told me last week that the fourth dose is “an unanswered scientific question
for people with a normal immune system.” A third member of the committee, Paul
Offit of the Children’s Hospital of Philadelphia, told
the Atlantic that he advised his 20-something son to forgo the third shot,
which the FDA recommends for everyone 12 and over. ... Two top FDA officials
quit the agency in September complaining of undue pressure to authorize
boosters. Marion Gruber, former director of the Office of Vaccine Research and
Review, and her deputy, Philip Krause, later
wrote about the lack of data to support a broad booster authorization.
Hours after the FDA authorized the fourth dose, the Centers for Disease Control
and Prevention gave its formal approval to the move—also without convening its
external vaccine experts
AND then there are these articles, among others, voicing scientific and
medical skepticism about the risk-benefit calculus being deployed by the FDA
and WH:
Philip Krause and Luciana Borio March 28, 2022 You Likely
Don’t Need a Fourth Covid Shot Unless you’re at high risk, the initial two
vaccine doses are enough. The Wall Street Journal. https://www.wsj.com/articles/you-likely-dont-need-a-fourth-covid-shot-booster-dose-pfizer-moderna-vaccine-omicron-ba-2-ba2-11648498217
Dr. Krause is a consultant to the World Health Organization
and was deputy director of FDA’s Office of Vaccines Research and Review,
2011-21. Dr. Borio is a senior fellow for global health at the Council on
Foreign Relations and was director for medical and biodefense preparedness
policy at the National Security Council, 2017-19
See also Constanze Kuhlmann, Carla Konstanze
Mayer, Mathilda Claassen, Tongai Maponga, Wendy A Burgers, Roanne Keeton, et al. (2022, January 18,
2022). Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster
dose. The Lancet.DOI:https://doi.org/10.1016/S0140-6736(22)00090-3
IGNORING CONTRARY EVIDENCE
Israeli study shows 4th shot of
COVID-19 vaccine not able to block Omicron. (2022, January 17). MSN.Com https://www.msn.com/en-us/news/world/israeli-study-shows-4th-shot-of-covid-19-vaccine-not-able-to-block-omicron/ar-AASRT8Q
Lock, S. (2022, January 11). Repeated Covid boosters not
viable strategy against new variants, WHO experts warn. https://www.theguardian.com/world/2022/jan/12/repeated-covid-boosters-not-viable-strategy-against-new-variants-who-experts-warn
CENSORED
This study cited here was algorithmically censored in 2021. I know because
my posted comments online with this doi (article locator number) were censored.
Here is the citation and the link
to the press release for your reference:
SARS-CoV-2
Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
Yuyang Lei , Jiao Zhang , Cara R. Schiavon, Ming He, Lili Chen, Hui Shen, Yichi
Zhang, Qian Yin , Yoshitake Cho , Leonardo Andrade , Gerald S. Shadel , Mark
Hepokoski, Ting Lei, Hongliang Wang, Jin hang, Jason X.-J. Yuan, Atul Malhotra,
Uri Manor, Shengpeng Wang, Zu-Yi Yuan, John Y-J. Shyy Originally published31
Mar 2021https://doi.org/10.1161/CIRCRESAHA.121.318902Circulation Research.
2021;128:1323–1326
Other studies documented also that the spike protein, detached from the
rest of the virus, elicits cell signalling in human cells, which "may
promote pulmonary vacular remodeling and PAH [pulmonary arterial hypertension]
as well as other cardiovascular complications":
Yuichiro J. Suzuki1,* and Sergiy G. Gychka SARS-CoV-2
Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for
Possible Consequences of COVID-19 Vaccines. Vaccines 2021, 9(1), 36; https://doi.org/10.3390/vaccines9010036
Here is an instructive excerpt from this research study:
3.
SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Cells
It was found that the treatment of cultured primary human pulmonary artery
smooth muscle cells (SMCs) or human pulmonary artery endothelial cells with the
recombinant SARS-CoV-2 spike protein S1 subunit is sufficient to promote cell
signaling without the rest of the viral components [21].
Furthermore, our analysis of the postmortem lung tissues of patients who died
of COVID-19 has determined that these patients exhibited pulmonary vascular
wall thickening, a hallmark of pulmonary arterial hypertension (PAH) [21].
Based on these results, we proposed that the SARS-CoV-2 spike protein (without
the rest of the viral components) triggers cell signaling events that may
promote pulmonary vascular remodeling and PAH as well as possibly other
cardiovascular complications [21,22].
I suspect that the hundreds of instances of myocarditis and pericarditis investigated
but then dismissed as “rare” by the FDA are the tip of the iceberg. See the FDA
presentation here if it hasn't been censored already: https://www.fda.gov/media/150054/download
One study provides an explanation of how this might occur in their
description of the circulation of the spike protein:
Circulating SARS-CoV-2 Vaccine Antigen Detected in the
Plasma of mRNA-1273 Vaccine Recipients
Alana F. Ogata†1,2,3, Chi-An Cheng†1,2,3, Michaël Desjardins†3,4,5, Yasmeen
Senussi1, Amy C. Sherman3,4, Megan Powell4, Lewis Novack4, Salena Von4,
Xiaofang Li6, Lindsey R. Baden*3,4,6, David R. Walt*1,2,3. Downloaded from https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab465/6279075
by guest on 25 May 2021
We have passed the rubicon so well described by G. Agamben, before he was censored and cancelled for challenging the governmental response to the pandemic.